Literature DB >> 8221657

CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.

T Sethi1, T Herget, S V Wu, J H Walsh, E Rozengurt.   

Abstract

Gastrin, cholecystokinin (CCK), and CCK-related peptides comprise a hormonal family characterized by an identical carboxy-terminal amino acid sequence, a domain critical for receptor binding. The addition of gastrin to small cell lung cancer (SCLC) cells causes a rapid and transient increase in the intracellular concentration of calcium ([Ca2+]i). Furthermore, gastrin acts as a direct growth factor through CCKB/gastrin receptors. We report here that the expression of the mRNA coding for CCKB/gastrin receptors correlates with the responsiveness of SCLC cells to gastrin in terms of Ca2+ mobilization and stimulation of clonal growth in semisolid medium. The GLC19 SCLC cell line had no detectable expression of CCKB/gastrin receptor mRNA. Accordingly, gastrin (1-100 nM) did not cause any measurable increase in [Ca2+]i. In contrast, the addition of cholecystokinin residues 26-33 (CCK-8) caused a rapid and transient increase in [Ca2+]i in this cell line. CCK-8 mobilized Ca2+ in a dose-dependent manner in the nanomolar range (half-maximal stimulatory concentration = 12 nM). Furthermore, the selective CCKA antagonist CAM-1481 inhibited the increase in [Ca2+]i induced by CCK-8 (half-maximal inhibitory concentration = 3 nM) in GLC19 but not in H510 cells. The selective CCKB/gastrin antagonist blocked the increase in [Ca2+]i induced by CCK-8 (half-maximal inhibitory concentration = 80 pM) in H510 but not in GLC19 cells. Thus, the effects of CCK-8 are mediated through CCKA receptors in GLC19 cells and via CCKB/gastrin receptors in H510 cells. CCK-8 markedly stimulated colony formation in GLC19 cells in a dose-dependent manner in the nanomolar range, whereas over the same concentration range, gastrin had no effect on clonal growth. CAM-1481 inhibited the CCK-stimulated colony formation in GLC19 but not in H510 cells. Our results show, for the first time, that CCKA receptors can mediate Ca2+ mobilization and growth in SCLC cells and that SCLC cells express two distinct functional CCK receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221657

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Immunogold labelling of neuroendocrine peptides with special reference to antibody specificity and multiple staining techniques.

Authors:  L I Larsson
Journal:  Histochem Cell Biol       Date:  1996-07       Impact factor: 4.304

2.  Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.

Authors:  P Cordelier; J P Estève; C Bousquet; N Delesque; A M O'Carroll; A V Schally; N Vaysse; C Susini; L Buscail
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  [99mTc]Tc-DGA1, a Promising CCK2R-Antagonist-Based Tracer for Tumor Diagnosis with Single-Photon Emission Computed Tomography.

Authors:  Aikaterini Kaloudi; Panagiotis Kanellopoulos; Thorsten Radolf; Oleg G Chepurny; Maritina Rouchota; George Loudos; Fritz Andreae; George G Holz; Berthold Artur Nock; Theodosia Maina
Journal:  Mol Pharm       Date:  2020-07-07       Impact factor: 4.939

4.  Gastrin-cholecystokinin(B) receptor expression in AGS cells is associated with direct inhibition and indirect stimulation of cell proliferation via paracrine activation of the epidermal growth factor receptor.

Authors:  A Varro; P J Noble; L E Wroblewski; L Bishop; G J Dockray
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

5.  CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Paola Moreno; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2015-03-12       Impact factor: 3.444

6.  Activation of a nerve injury transcriptional signature in airway-innervating sensory neurons after lipopolysaccharide-induced lung inflammation.

Authors:  Melanie Maya Kaelberer; Ana Isabel Caceres; Sven-Eric Jordt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

7.  Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein.

Authors:  G S Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

8.  Mechanisms of action of CCK to activate central vagal afferent terminals.

Authors:  Richard C Rogers; Gerlinda E Hermann
Journal:  Peptides       Date:  2008-07-04       Impact factor: 3.750

9.  Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice.

Authors:  Qing He; Hua Gao; Meng Gao; Shengmei Qi; Yingqi Zhang; Junzhi Wang
Journal:  J Cancer       Date:  2015-03-08       Impact factor: 4.207

10.  Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition.

Authors:  C M Waters; A C MacKinnon; J Cummings; U Tufail-Hanif; D Jodrell; C Haslett; T Sethi
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.